廣西扶綏縣肝癌家系人群TSPAN8基因單核苷酸多態(tài)性與肝癌遺傳易感性研究
發(fā)布時(shí)間：2018-08-08 21:19
【摘要】：目的:探討TSPAN8基因rs1051334、rs2270587位點(diǎn)單核苷酸多態(tài)性與廣西扶綏縣肝癌高發(fā)區(qū)肝癌家系遺傳易感性的關(guān)系。方法:采用病例-對(duì)照研究方法,收集廣西扶綏縣肝癌高發(fā)地區(qū)20個(gè)肝癌高發(fā)家系(共79例,其中肝癌患者20例及直系親屬59例)及10個(gè)正常對(duì)照家系(共40例)作為研究對(duì)象,運(yùn)用飛行時(shí)間質(zhì)譜分析技術(shù)(MALDI-TOF)檢測(cè)TSPAN8基因rs1051334、rs2270587位點(diǎn)基因型。運(yùn)用SPSS 17.0軟件對(duì)數(shù)據(jù)進(jìn)行統(tǒng)計(jì)分析。所有統(tǒng)計(jì)學(xué)分析結(jié)果采用雙側(cè)概率檢驗(yàn),以P0.05為差異具有統(tǒng)計(jì)學(xué)意義。根據(jù)Hardy-Weinberg遺傳平衡定律檢測(cè)各組人群基因型吻合度。使用χ~2檢驗(yàn)計(jì)算各組人群等位基因型分布差異。并應(yīng)用非條件Logistic回歸模型分析該基因候選位點(diǎn)基因型多態(tài)性與肝癌家系遺傳易感性的關(guān)系。結(jié)果:1.(1)肝癌高發(fā)家系組人群TSPAN8基因rs1051334位點(diǎn)攜帶TT、TG、GG3種基因型,其分布頻率分別是55.7%、34.2%、10.1%;對(duì)照家系組人群TSPAN8基因rs1051334位點(diǎn)攜帶TT、TG、GG3種基因型,其分布頻率分別是62.2%、35.1%、2.7%。兩組各基因型實(shí)際值與期望值吻合度好(P0.05)。(2)肝癌高發(fā)家系組人群TSPAN8基因rs2270587位點(diǎn)攜帶CC、CT、TT3種基因型,其分布頻率分別是67.1%、31.6%、1.3%;對(duì)照家系組人群TSPAN8基因rs2270587位點(diǎn)攜帶CC、CT、TT3種基因型,其頻率分別是50.0%、45.0%、5.0%。兩組各基因型實(shí)際值與期望值吻合度好(P0.05)。2.(1)肝癌高發(fā)家系患者組、肝癌高發(fā)家系非患者組及正常對(duì)照家系組人群TSPAN8基因rs1051334位點(diǎn)T等位基因頻率分別為72.5%、72.9%和79.7%,G等位基因頻率分別為27.5%、27.1%、20.3%。肝癌高發(fā)家系患者組與非患者組等位基因頻率分布無顯著差異(χ~2=0.002,P=0.963),肝癌高發(fā)家系患者組與正常對(duì)照家系組等位基因頻率分布無顯著差異(χ~2=0.771,P=0.380)。在肝癌高發(fā)家系非患者組人群中,攜帶GT基因型的個(gè)體發(fā)生HCC的風(fēng)險(xiǎn)是攜帶TT基因型個(gè)體的1.15倍(95%CI為0.32~4.13);攜帶GG基因型的個(gè)體發(fā)生HCC的風(fēng)險(xiǎn)是攜帶TT基因型個(gè)體的0.62倍(95%CI為0.08~4.87)。在正常對(duì)照家系組人群中,攜帶GT基因型的個(gè)體發(fā)生HCC的風(fēng)險(xiǎn)是攜帶TT基因型個(gè)體的2.82倍(95%CI為0.52~15.27),攜帶GG基因型的個(gè)體發(fā)生HCC的風(fēng)險(xiǎn)是攜帶TT基因型個(gè)體的3.61倍(95%CI為0.21~63.44),但差異均無統(tǒng)計(jì)學(xué)意義(P0.05)。(2)肝癌高發(fā)家系患者組、非患者組及正常對(duì)照家系組人群TSPAN8基因rs2270587位點(diǎn)C等位基因頻率分別為90.0%、80.5%和72.5%,T等位基因頻率分別為10.0%、19.5%、27.5%。肝癌高發(fā)家系患者組與非患者組等位基因頻率分布無顯著差異(χ~2=1.899,P=0.168),肝癌高發(fā)家系患者組與正常對(duì)照家系組等位基因頻率分布有顯著差異(χ~2=4.812,P=0.028),正常對(duì)照家系組人群攜帶T等位基因型的個(gè)體發(fā)生HCC的風(fēng)險(xiǎn)是攜帶C等位基因型個(gè)體的0.29倍(95%CI為0.09~0.92)。在肝癌家系非患者組人群中,攜帶CT基因型的個(gè)體發(fā)生HCC的風(fēng)險(xiǎn)是攜帶CC基因型個(gè)體的0.42倍(95%CI為0.11~1.66),但未見顯著差異(P0.05),攜帶TT基因型的個(gè)體發(fā)生肝癌的風(fēng)險(xiǎn)無法計(jì)算出來。在正常對(duì)照家系組人群中,攜帶CT基因型的個(gè)體發(fā)生HCC的風(fēng)險(xiǎn)是攜帶CC基因型個(gè)體的0.34倍(95%CI為0.07~1.59),但未見顯著差異(P0.05),攜帶TT基因型的個(gè)體發(fā)生肝癌的風(fēng)險(xiǎn)無法計(jì)算。結(jié)論:1.在廣西扶綏縣人群中,TSPAN8基因rs1051334位點(diǎn)、rs2270587位點(diǎn)各基因型分布符合Hardy-Weinberg遺傳平衡定律;2.TSPAN8基因rs1051334位點(diǎn)單核苷酸多態(tài)性與廣西扶綏縣人群肝癌家系的遺傳易感性無明顯相關(guān)性;3.TSPAN8基因rs2270587位點(diǎn)單核苷酸多態(tài)性與廣西扶綏縣人群肝癌家系的遺傳易感性有相關(guān)性,rs2270587位點(diǎn)T等位基因?yàn)閺V西扶綏縣人群HCC發(fā)生的保護(hù)因素。
[Abstract]:Objective: To investigate the relationship between the single nucleotide polymorphism of TSPAN8 gene rs1051334 and rs2270587 loci and the genetic susceptibility to HCC families in the high incidence area of liver cancer in Fusui County, Guangxi. Methods: a case control study was used to collect 20 HCC families (79 cases, including 20 cases of liver cancer and 59 cases of direct relatives) in the high incidence area of liver cancer in Fusui County, Guangxi. 10 normal controls (a total of 40 cases) were used as the research object, using time of flight mass spectrometry (MALDI-TOF) to detect TSPAN8 gene rs1051334 and rs2270587 genotype. The data were statistically analyzed using SPSS 17 software. All statistical analysis results were tested by bilateral probability, and P0.05 was statistically significant. According to H Ardy-Weinberg's law of genetic balance was used to detect the genotypic degree of genotype in each group. The difference of genotype distribution in each group was calculated using the chi square ~2 test. The relationship between the genotype polymorphism of the candidate loci and the genetic susceptibility of HCC families was analyzed by the non conditional Logistic regression model. Results: 1. (1) TSPAN8 of the HCC family group The gene rs1051334 loci carried TT, TG, and GG3 genotypes, and their distribution frequencies were 55.7%, 34.2%, 10.1% respectively. The rs1051334 loci of TSPAN8 gene in the control family group were carried by TT, TG, and GG3 genotypes, and the distribution frequencies were 62.2%, 35.1%, and 2.7%. two respectively. (2) the hepatocellular carcinoma HCC group group TS The rs2270587 loci of the PAN8 gene carry CC, CT, and TT3 genotypes, the frequencies of which are 67.1%, 31.6%, 1.3% respectively. The TSPAN8 gene rs2270587 loci of the control family group carry CC, CT, TT3 genotypes, and the frequencies of the genotype are 50%, 45%, and 5.0%. two, respectively. The frequency of T allele of TSPAN8 gene rs1051334 loci of HCC non patient group and normal control family group was 72.5%, 72.9% and 79.7% respectively, and the frequency of G allele was 27.5% and 27.1% respectively. There was no significant difference in the allele frequency distribution of 20.3%. HCC group and non patient group (x ~2=0.002, P=0.963), HCC high hair family. There was no significant difference in the allele frequency distribution between the group and the normal control group (x ~2=0.771, P=0.380). In the non patient group of the HCC family, the risk of HCC carrying GT genotype was 1.15 times that of the TT genotype (95%CI 0.32~4.13), and the risk of HCC carrying GG genotype was TT based. 0.62 times (95%CI 0.08~4.87) of the type individual. In the normal control group, the risk of HCC in individuals carrying GT genotype was 2.82 times as high as that of the TT genotype (95%CI 0.52~15.27), and the risk of HCC carrying GG genotype was 3.61 times that of the TT genotype (95%CI 0.21~63.44), but the difference was not statistically significant. (2) (2) the frequency of the C allele of the rs2270587 locus of the TSPAN8 gene was 90%, 80.5% and 72.5% in the non patient group and the normal control group, respectively, and the frequency of the T allele was 10% and 19.5%, respectively, and there was no significant difference in the allele frequency distribution between the HCC patients and the non patients group (x ~2=1). .899, P=0.168), the allele frequency distribution of HCC patients was significantly different from that of normal control family group (x ~2=4.812, P=0.028). The risk of HCC in individuals carrying T allele in normal control family group was 0.29 times as much as C allelic individuals (95%CI 0.09~0.92). The risk of HCC with the CT genotype was 0.42 times that of the CC genotype (95%CI 0.11~1.66), but there was no significant difference (P0.05). The risk of cancer carrying the TT genotype could not be calculated. In the normal control family group, the risk of carrying HCC in CT based individuals was carried by the CC genotype individual. 0.34 times (95%CI 0.07~1.59), but no significant difference (P0.05), the risk of hepatocellular carcinoma with TT genotype could not be calculated. Conclusion: 1. in the population of the TSPAN8 gene in Fusui County, Guangxi, the genotype distribution of the rs2270587 loci conforms to the Hardy-Weinberg genetic balance law, and the 2.TSPAN8 gene rs1051334 loci single nucleotide. There is no significant correlation between polymorphism and genetic susceptibility to liver cancer families in Fusui County, Guangxi. The single nucleotide polymorphism of 3.TSPAN8 gene rs2270587 loci is related to the genetic susceptibility of liver cancer families in Fusui County of Guangxi, and the rs2270587 locus T allele is the protection factor of HCC in Fusui County of Guangxi.
【學(xué)位授予單位】：廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R735.7
本文編號(hào)：2173066
[Abstract]:Objective: To investigate the relationship between the single nucleotide polymorphism of TSPAN8 gene rs1051334 and rs2270587 loci and the genetic susceptibility to HCC families in the high incidence area of liver cancer in Fusui County, Guangxi. Methods: a case control study was used to collect 20 HCC families (79 cases, including 20 cases of liver cancer and 59 cases of direct relatives) in the high incidence area of liver cancer in Fusui County, Guangxi. 10 normal controls (a total of 40 cases) were used as the research object, using time of flight mass spectrometry (MALDI-TOF) to detect TSPAN8 gene rs1051334 and rs2270587 genotype. The data were statistically analyzed using SPSS 17 software. All statistical analysis results were tested by bilateral probability, and P0.05 was statistically significant. According to H Ardy-Weinberg's law of genetic balance was used to detect the genotypic degree of genotype in each group. The difference of genotype distribution in each group was calculated using the chi square ~2 test. The relationship between the genotype polymorphism of the candidate loci and the genetic susceptibility of HCC families was analyzed by the non conditional Logistic regression model. Results: 1. (1) TSPAN8 of the HCC family group The gene rs1051334 loci carried TT, TG, and GG3 genotypes, and their distribution frequencies were 55.7%, 34.2%, 10.1% respectively. The rs1051334 loci of TSPAN8 gene in the control family group were carried by TT, TG, and GG3 genotypes, and the distribution frequencies were 62.2%, 35.1%, and 2.7%. two respectively. (2) the hepatocellular carcinoma HCC group group TS The rs2270587 loci of the PAN8 gene carry CC, CT, and TT3 genotypes, the frequencies of which are 67.1%, 31.6%, 1.3% respectively. The TSPAN8 gene rs2270587 loci of the control family group carry CC, CT, TT3 genotypes, and the frequencies of the genotype are 50%, 45%, and 5.0%. two, respectively. The frequency of T allele of TSPAN8 gene rs1051334 loci of HCC non patient group and normal control family group was 72.5%, 72.9% and 79.7% respectively, and the frequency of G allele was 27.5% and 27.1% respectively. There was no significant difference in the allele frequency distribution of 20.3%. HCC group and non patient group (x ~2=0.002, P=0.963), HCC high hair family. There was no significant difference in the allele frequency distribution between the group and the normal control group (x ~2=0.771, P=0.380). In the non patient group of the HCC family, the risk of HCC carrying GT genotype was 1.15 times that of the TT genotype (95%CI 0.32~4.13), and the risk of HCC carrying GG genotype was TT based. 0.62 times (95%CI 0.08~4.87) of the type individual. In the normal control group, the risk of HCC in individuals carrying GT genotype was 2.82 times as high as that of the TT genotype (95%CI 0.52~15.27), and the risk of HCC carrying GG genotype was 3.61 times that of the TT genotype (95%CI 0.21~63.44), but the difference was not statistically significant. (2) (2) the frequency of the C allele of the rs2270587 locus of the TSPAN8 gene was 90%, 80.5% and 72.5% in the non patient group and the normal control group, respectively, and the frequency of the T allele was 10% and 19.5%, respectively, and there was no significant difference in the allele frequency distribution between the HCC patients and the non patients group (x ~2=1). .899, P=0.168), the allele frequency distribution of HCC patients was significantly different from that of normal control family group (x ~2=4.812, P=0.028). The risk of HCC in individuals carrying T allele in normal control family group was 0.29 times as much as C allelic individuals (95%CI 0.09~0.92). The risk of HCC with the CT genotype was 0.42 times that of the CC genotype (95%CI 0.11~1.66), but there was no significant difference (P0.05). The risk of cancer carrying the TT genotype could not be calculated. In the normal control family group, the risk of carrying HCC in CT based individuals was carried by the CC genotype individual. 0.34 times (95%CI 0.07~1.59), but no significant difference (P0.05), the risk of hepatocellular carcinoma with TT genotype could not be calculated. Conclusion: 1. in the population of the TSPAN8 gene in Fusui County, Guangxi, the genotype distribution of the rs2270587 loci conforms to the Hardy-Weinberg genetic balance law, and the 2.TSPAN8 gene rs1051334 loci single nucleotide. There is no significant correlation between polymorphism and genetic susceptibility to liver cancer families in Fusui County, Guangxi. The single nucleotide polymorphism of 3.TSPAN8 gene rs2270587 loci is related to the genetic susceptibility of liver cancer families in Fusui County of Guangxi, and the rs2270587 locus T allele is the protection factor of HCC in Fusui County of Guangxi.
【學(xué)位授予單位】：廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R735.7
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 武金才;周開倫;陳家誠;陳良;唐榮;陳騁;許達(dá)峰;鄭進(jìn)方;張震生;李灼日;;Tspan8過表達(dá)與肝癌上皮間變及轉(zhuǎn)移的關(guān)系[J];中華肝膽外科雜志;2016年11期
2 王春玲;陳良;周開倫;張震生;唐榮;陳平平;許達(dá)峰;陳騁;李灼日;武金才;;Tspan8過表達(dá)與肝癌轉(zhuǎn)移潛能及預(yù)后的關(guān)系[J];中國普通外科雜志;2016年07期
3 Sarah Heiler;Zhe Wang;Margot Z?ller;;Pancreatic cancer stem cell markers and exosomes- the incentive push[J];World Journal of Gastroenterology;2016年26期
4 黎沙;岳惠芬;崔英;梁新強(qiáng);劉海洲;羅蘭英;楊亮;;廣西扶綏縣原發(fā)性肝癌家系的調(diào)查分析[J];中國癌癥防治雜志;2015年03期
5 魏礦榮;彭俠彪;梁智恒;岑惠珊;;全球肝癌流行概況[J];中國腫瘤;2015年08期
6 方婷婷;劉彬彬;;四次跨膜超家族蛋白3在腫瘤中的研究進(jìn)展[J];醫(yī)學(xué)綜述;2015年05期
7 任宇鵬;宋純;孟慶凱;;Tspan8在結(jié)腸癌細(xì)胞中的表達(dá)及小干擾RNA干擾后對(duì)SW620細(xì)胞功能的影響[J];中國醫(yī)科大學(xué)學(xué)報(bào);2015年01期
8 吳慕云;王希成;;應(yīng)用下一代測(cè)序技術(shù)檢測(cè)腫瘤單核苷酸多態(tài)性研究進(jìn)展[J];廣東藥學(xué)院學(xué)報(bào);2014年04期
9 楊春曉;張玉;師少軍;;SNP基因分型檢測(cè)技術(shù)及應(yīng)用進(jìn)展[J];中國藥師;2013年06期
10 王捷;陳汝福;唐啟彬;;原發(fā)性肝癌多學(xué)科治療模式[J];肝膽外科雜志;2013年01期
，本文編號(hào)：2173066
本文鏈接：http://www.sikaile.net/kejilunwen/jiyingongcheng/2173066.html
最近更新
教材專著
